KCK Group
Private Investment GroupCampbell, United StatesSee on the mapkckmedtech.com
Health specialist
KCK Medtech is an evergreen investment fund that invests in medical device companies. It provides long-term support to medical technology businesses.
- 2
- Portfolio companies on reccy
- 2
- Hiring now
- 36
- Open roles in the portfolio
- Aug 2020
- Latest portfolio round
Hiring now in the portfolio36
Apply on each company's site- Posted 1d ago
Associate Product Manager
Mainstay Medical · San Diego, CA
- Posted 1d ago
Associate Therapy Consultant - Fresno
NeuroPace · Fresno, California
- Posted 2d ago
Associate Therapy Consultant - Birmingham
NeuroPace · Birmingham, AL
- Posted 2d ago
Therapy Specialist (Sales Associate)
Mainstay Medical · North Carolina, NC
- Posted 3d ago
Associate Therapy Consultant - San Francisco Bay Area
NeuroPace · San Francisco, CA
- Posted 4d ago
Therapy Specialist (Sales Associate)
Mainstay Medical · AL, US
- Posted 4d ago
Therapy Specialist (Sales Associate)
Mainstay Medical · KY, US
- Posted 4d ago
Associate Therapy Consultant - Fort Worth
NeuroPace · Fort Worth, Texas
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- NeuroPaceMountain View, CA
EEG and neural monitoring · Neuromodulation
- Aug 2025Grant · $6.8M
- Jun 2025Post-IPO Debt · $75M
- Feb 2025Post-IPO Equity · $74.8M
- Jun 2021Grant · $9.3M
- Aug 2020Convertible Note · $34M
- Aug 2020Venture Round · $33MLed
- Mainstay MedicalSan Diego, CA
Neuromodulation
- Jun 2026Series B Preferred Share Subscription · $60M
- Feb 2024Private Equity Round · $125M
- Apr 2021Debt Financing · $50M
- Feb 2021Private Equity Round · $108M
- Feb 2018Post-IPO Equity · $37.5M
- Jun 2016Post-IPO Equity · $33.8M
Rounds marked Led list KCK Group as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Aug 2020
NeuroPace · Venture Round $33MLead
With Accelmed Partners II LP, Accelmed Partners, KCK, Johnson & Johnson Development Corporation, Revelation Partners, Soleus Capital, OrbiMed Advisors
Portfolio in the news
From the Cortex · last 12 months- Feb 2026
- Dec 2025